معرفی
Prof. Adriaan Voors is a Cardiologist and Professor at the Faculty of Medical Sciences, University of Groningen. He specializes in heart failure research and clinical trials, with a focus on biomarkers, acute heart failure management, and epidemiological studies. His roles include Chief Executive Officer of G-CURE BV and consulting positions with pharmaceutical companies like Bayer, Boehringer, Merck, and Pfizer. He leads multiple international research initiatives, including principal investigator roles in the EMPULSE-HF, GALACTIC-HF, and METEORIC-HF trials, and chairs steering committees for major studies such as FINEARTS and AVANTI-HF. Voors also coordinates the RECONNEXT grant funded by CVON Hartstichting and manages research grants from Roche Diagnostics and Novo Nordisk.
His research interests span clinical cardiology, acute heart failure outcomes, and translational biomarker development. Key projects involve evaluating novel therapies and diagnostic tools for heart failure subtypes. Collaborations with global pharmaceutical partners and leadership in large-scale trials reflect his expertise in bridging academic research with clinical practice.
Voors has contributed to over 800 publications, with recent work focusing on alcohol consumption’s impact on heart failure, biomarker discovery (e.g., BMP10), and composite endpoint analysis in clinical trials. His work emphasizes improving patient outcomes through evidence-based strategies and innovative therapies.
